In today’s environment where drug companies are being monitored closely (take TAP’s recent lawsuit in the Boston area for instance) for physician kickbacks for prescribing drugs, comes this story from Italy:
A two-year investigation by the financial brigade found that the Italian subsidiary of Glaxo had mounted an illegal incentives scheme involving 4,713 people, including 4,440 doctors.
Glaxo clearly wasn’t subtle in their efforts to influence physicians:
. . . Freebies doled out to doctors across Italy included all-expenses-paid travel, cash or free pharmaceutical drugs, the police found.
Related posts:
- Think the physician-pharma relationship is bad here?
- Cash-only medicine doesn’t necessarily mean expensive care
- What’s better than $4 drugs?
- Medical marijuana, the new cash-only fad
- The economy, plastic surgery, and how it’s affecting cash only medicine
- Did Medscape use CME to illegally promote off-label use of drugs for rheumatoid arthritis?
- A lawyer questions the concept prescription drugs
KevinMD.com on Facebook
Comments on this entry are closed.